John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 22,675 shares at $12.60 ($287K) on 2026-08-20, disclosed to the SEC on 2026-08-24.
Scheduled sale ($287k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.60 | 19,890 | $251K | 87.4% |
| 2 | $13.00 | 2,785 | $36K | 12.6% |
| Total | $12.65 avg | 22,675 | $287K | 100% |
| Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |
| NTLA | SELL | 2023-01-06 | $497K | — | Filing → |